徐州沛县华佗四维预约电话徐州怀孕有必要做四维彩超吗,徐州三个多月能做四维彩超,徐州无痛胃镜 大概多少钱,徐州四维超多少钱啊,徐州什么时间段做四维好,徐州市医院有四维彩超吗,徐州四维什么时候可以做

The White House says President Donald Trump was never briefed on intelligence that Russia had put a bounty on U.S. soldiers in Afghanistan because there wasn’t corroborating evidence. But former intelligence officials say presidents are routinely informed about intelligence even when it’s not definitively confirmed. Former intelligence officials says it strains credulity to think that Trump wouldn’t have been told of something so important, whether corroborated or not. Intelligence that may be on shaky ground today may foreshadow tomorrow’s calamity, so briefers are expected to ensure presidents have the fullest possible picture to prepare for something that may soon require full attention. 707

The Republican National Committee has withdrawn from a joint fundraising agreement with Roy Moore, according to a Federal Election Commission filing posted Tuesday, as the GOP establishment continues to break ties with the Alabama Senate candidate.The National Republican Senatorial Committee was the first to drop itself from the agreement, which benefits Moore's campaign, ending its participation last Friday, according to FEC filings. 466

The US Food and Drug Administration on Thursday announced the approval of?the first generic version of EpiPen.The auto-injector pen delivers the drug epinephrine to patients experiencing a severe allergic reaction that, if untreated, could develop into the life-threatening condition of anaphylaxis. The medication is delivered into a muscle as a single dose, like a shot, through an injector pen with a spring.Allergies from food, bug bites, medications and latex can cause life-threatening reactions.The newly approved generic is made by Teva Pharmaceuticals and offers an alternative for patients who, until now, have been able to use only the brand-name EpiPen made by Mylan. It is approved in a smaller dose for children, as well.There are two other brand products on the market for a severe allergic reaction: Adrenaclick and Auvi-Q.The newly approved option made by Teva is the only approved non-brand option and can be substituted only for Mylan's EpiPen."Today's approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. is part of our longstanding commitment to advance access to lower cost, safe and effective generic alternatives once patents and other exclusivities no longer prevent approval," FDA Commissioner Dr. Scott Gottlieb said in a statement announcing the approval.In recent years, Mylan came under fire for a price increase that put the product out of reach for many who needed to keep the drug on hand. 1488

The Senate has passed a defense spending bill that President Donald Trump has said he plans to veto, according to the Associated Press.The National Defense Authorization Act passed the Senate with a 84 to 13 Friday. The annual bill affirms a 3% pay raise to U.S. troops and unlocks billions in military spending.The bill passed despite an attempt from Sen. Rand Paul, R-Kentucky, to filibuster the bill and delay its passage. Paul said Thursday he opposed the bill because it limited Trump's ability to withdraw troops from the Middle East before he leaves office.Trump has threatened to veto the bill unless lawmakers include a provision that would remove Section 230 from the 1996 Communications Decency Act. That section protects tech companies from being sued for content that other people post on their website.Conservative lawmakers have attacked the provision in recent years, saying that the protections have led social media conglomerates to develop a liberal bias on the social media sites. Proponents of the provision say it upholds free-market values in the marketplace of information.Congress is expected to override a potential veto from Trump. The House of Representatives easily passed the bill earlier this month with a vote of 335-78. 1260

The Trump campaign has dropped a central part of its lawsuit that seeks to delay the certification of election results in Pennsylvania, the state which proved to be the tipping point for Joe Biden in clinching the presidency.On Sunday, the Trump campaign dropped a portion of a lawsuit that alleged that more than 600,000 mail-in and absentee ballots were processed without Republican poll-watchers present. The claim has been a central part of President Donald Trump's argument that the 2020 election has been beset by widespread voter fraud.The Trump campaign's lawsuit now only focuses on claims that Republicans were "illegally disadvantaged" because some voters in Democratic-leaning counties were afforded the ability to fix mistakes on their mail-in ballots, a process called "curing." The Washington Post reports that the issue would likely only affect a small number of votes.Ballot curing is a process that takes place in several states. According to The Associated Press, there is no provision in Pennsylvania state law that prevents counties from affording voters the opportunity to cure ballots.Biden currently holds a lead of about 70,000 votes over Trump, with nearly all of the votes counted.Despite his campaign's altered lawsuit, Trump on Sunday continued to claim on Twitter — without providing evidence — that poll watchers "were thrown out of vote counting rooms in many of our States."Late Sunday evening, Trump tweeted, "I WON THE ELECTION!" a claim that quickly prompted Twitter to add a clarification to his message clarifying that "official sources have called this election differently." 1622